首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 在线期刊 2008年 => 5期 =>阿德福韦酯联合抗乙型肝炎转移因子..
阿德福韦酯联合抗乙型肝炎转移因子对慢性乙型肝炎的治疗研究
Effect of Anti-HB transfer factor and Adefovir Combination Therapy on Patients with Chronic-Hepatitis B and Influence on HBV DNA
文章发布日期:2009年09月29日  来源:  作者:朱宇佳  点击次数:1612次  下载次数:644次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的观察阿德福韦酯联合抗乙型肝炎转移因子对慢性乙型肝炎(CHB)的疗效及对HBV DNA的影响。方法184例CHB患者随机分为治疗组和对照组,治疗组92例为阿德福韦酯和抗乙型肝炎转移因子;对照组92例为单用阿德福韦酯,疗程均为12个月,每三个月分别检测肝功能、乙型肝炎病毒血清学标志物、HBV DNA。其中40例患者(每组20例)进行治疗前、后两次肝穿活检。结果在治疗12个月时,治疗组和对照组的HBV DNA差异有显著性意义(P<0.05),治疗组的HBV DNA表达量明显低于对照组,大部分患者肝组织病理有改善。结论阿德福韦酯联合抗乙型肝炎转移因子能在一定程度上提高治疗CHB的疗效,而其对HBV DNA的影响有待进一步的研究。
【Abstract】: Objective To observe the effect of combined application of anti-HB transfer factor and Adefovir in treating patients with chronic hepatitis B(CHB) and its influence on HBV DNA.Methods 184 patients were enrolled and randomized into two groups: the treated grorp(92 cases) and control group(92cases).The treated group received anti-HB transfer factor and Adefovir simultaneously for 12 months.The control group received Adefovir alone for 12 months Liver function,virological parameters,serum HBV DNA and HBV DNA were evaluated.Liver biopsy was taken before therapy and after 12 months treament in 40patients.Results After 12months treatment,there was no difference in HBV DNA negative rate between treated group and control groups(P>0.05).Most of liver histology were improved in 40 patients.Conclusions Combined application of anti-HB transfer factor and 1 Adefovir could enhance the therapeutic effect in treating CHB to certain extent,but effect on HBV DNA should be study further more.
【关键字】:慢性乙型肝炎; HBV DNA; 阿德福韦酯; 抗乙型肝炎转移因子
【Key words】: Chronic hepatitis B; HBV DNA; Adefovir; anti-HBV transfer factor
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号